|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$2,645
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Validation of a novel, adjuvant implant for post-metastatic skeletal lesions
|
1R43CA221553-01A1
|
$299,958
|
|
MARGULIES, BRYAN
|
FUSOLOGICS, LLC
|
|
University of Washington PhD Training in Big Data for Genomics and Neuroscience
|
5T32LM012419-04
|
$239,918
|
|
NOBLE, WILLIAM
|
UNIVERSITY OF WASHINGTON
|
|
UGI cancer studies - other
|
ZIA CP000185-10319
|
$186,019
|
$37,204
|
Dawsey, Sandy
|
DCEG (NCI)
|
|
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions
|
1K07CA225404-01A1
|
$148,457
|
|
SUDENGA, STACI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Transcriptional regulation of H. pylori-mediated gastric inflammation and cancer
|
1R01CA179511-01
|
$150,000
|
$150,000
|
Chen, Lin-Feng
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
Transcription Regulation in E. coli and H. pylori
|
ZIA BC 010632
|
$847,929
|
$423,964
|
Jin, Ding
|
CCR (NCI)
|
|
TRANSCRIPTION FACTORS IN INTESTINAL DIFFERENTIATION AND CANCER
|
5K00CA212433-03
|
$78,398
|
|
LO, YUAN-HUNG
|
STANFORD UNIVERSITY
|
|
Toward coupled multiphysics models of hemodynamics on leadership systems
|
5DP5OD019876-05
|
$390,995
|
|
RANDLES, AMANDA
|
DUKE UNIVERSITY
|
|
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
|
1R43CA228721-01
|
$299,607
|
|
AKPORIAYE, EMMANUEL
|
VEANA THERAPEUTICS, LLC
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$527,328
|
$79,099
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Timing is everything: applications in precision oncology for ER+ breast cancer
|
5R01CA211869-02
|
$50,575
|
|
MILLER, TODD
|
DARTMOUTH COLLEGE
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
5U10CA045809-25
|
$1,885,277
|
$18,853
|
FISCH, MICHAEL
|
UT MD ANDERSON CANCER CTR
|
|
The Role of the Microenvironment in Barretts Esophagus
|
5U54CA163004-07
|
$1,085,045
|
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of miRNA Network in Gastric Cancer
|
1R01CA177372-01
|
$150,000
|
$150,000
|
EL-RIFAI, WAEL
|
VANDERBILT UNIVERSITY MED CTR
|
|
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas
|
5R01CA131225-05
|
$295,150
|
$147,575
|
EL-RIFAI, WAEL
|
VANDERBILT UNIVERSITY MED CTR
|
|
The Novel Biopsy Needle Design and Delivery System to Minimize Needle Deflection and Optimize Needle Positioning to Improve Lesion Sampling Accuracy Using a Co-registered MRI/US Fusion Biopsy Platform
|
1R41CA228877-01
|
$172,437
|
|
MONTGOMERY, JEFFREY
|
PRODEVICE MEDICAL SUPPLIES AND EQUIPMENT
|
|
THE MECHANISM OF TSLP ANTI-TUMOR EFFECTS IN THE SKIN
|
5DP5OD021353-04
|
$434,999
|
|
DEMEHRI, SHADMEHR
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Golestan Cohort Study
|
ZIA CP000185-10361
|
$27,523
|
$8,257
|
Abnet, Christian
|
DCEG (NCI)
|
|
The EDRN Mesothelioma Biomarker Discovery Laboratory
|
5U01CA214195-03
|
$812,360
|
|
PASS, HARVEY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Tension-Stat3-miR-mediated metastasis
|
3R01CA192914-03S1
|
$25,178
|
|
WEAVER, VALERIE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Telomere length, cancer risk, and genetic determinants
|
ZIA CP010190-10371
|
$47,662
|
$4,766
|
Savage, Sharon
|
DCEG (NCI)
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$1,272,705
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Targets of Gene Overexpression at 17q in Gastric Tumorigenesis: Darpp32
|
2R01CA093999-12A1
|
$304,937
|
$304,937
|
EL-RIFAI, WAEL
|
VANDERBILT UNIVERSITY MED CTR
|
|
Targeting glioblastoma stem-like cells with custom-designed viral vectors
|
1R42CA228875-01
|
$300,000
|
|
WARRINGTON, KENNETH
|
LACERTA THERAPEUTICS, INC.
|
|
Tablet-Based Augmented Reality for Fast CT Guidance with Reduced Radiation
|
1R43CA228865-01
|
$224,529
|
|
FOROUGHI, PEZHMAN
|
CLEAR GUIDE MEDICAL, INC.
|
|
Surgical Consultants & Collaborative Research Involving Surgical Services at NIH
|
ZID SC 003800
|
$3,204,789
|
$160,239
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Summer Program to Advance Research Careers (SPARC)
|
5R25CA214256-02
|
$267,323
|
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Stress Induction of Glucose Regulated Protein GRP78/BiP
|
5R01CA027607-38
|
$462,000
|
|
LEE, AMY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Stomach cancer in Poland
|
ZIA CP010136-03140
|
$11,993
|
$11,993
|
Liao, Linda
|
DCEG (NCI)
|
|
Sprayable, Prompt Color Changing Dye to Delineate Ovarian Cancer During Surgery
|
1R43CA224579-01A1
|
$229,603
|
|
GRAY, BRIAN
|
MOLECULAR TARGETING TECHNOLOGIES, INC.
|
|
Splice sensors for cancer drug discovery
|
2R44CA206804-02
|
$603,137
|
|
SOMALINGA, BALAJEE
|
LUCERNA, INC.
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$237,100
|
$130,405
|
Rothman, Nat
|
DCEG (NCI)
|
|
Serum biomarkers for early detection of H. pylori-associated gastric cancer
|
5R01CA136647-05
|
$280,710
|
$280,710
|
SOLNICK, JAY
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer
|
1R44CA224619-01A1
|
$196,647
|
|
JUNKER, WADE
|
SANGUINE DIAGNOSTICS AND THERAPEUTICS
|
|
Role of Th1/17 in gastric tumor initiation triggered by CTLA4 dysregulation
|
1R21CA178675-01
|
$133,545
|
$133,545
|
Chen, Zhibin
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Repurposing of Pyrvinium Pamoate for Familial Adenomatous Polyposis (FAP)
|
1R44CA228840-01
|
$297,882
|
|
ORTON, DARREN
|
STEMSYNERGY THERAPEUTICS, INC.
|
|
Repression via Facultative Heterochomatin
|
5R01CA199652-16
|
$362,306
|
|
REINBERG, DANNY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment
|
2R44CA206801-02
|
$920,127
|
|
HAN, XIAO
|
CLARIX IMAGING CORPORATION
|
|
RAPID: An Extremely Fast Monte Carlo Dose Computing Software for Nuclear Medicine
|
1R43CA221491-01A1
|
$291,615
|
|
WICKRE, PAUL
|
VOXIMETRY, LLC
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and pa
|
ZIA CP010131-04134
|
$389,276
|
$77,855
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Programmable Individualized NRT Merged With Digital Behavioral Support
|
5R44CA171786-05
|
$1,000,000
|
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
|
Predictive signatures in breast cancer using multiplexed ion beam imaging
|
5DP5OD019822-05
|
$401,249
|
|
ANGELO, ROBERT
|
STANFORD UNIVERSITY
|
|
Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
|
1R43CA224454-01A1
|
$225,000
|
|
GREENBERG, MILTON
|
VIVREON BIOSCIENCES, LLC
|
|
Preclinical Parahydrogen Hyperpolarizer Device
|
1R43CA224847-01A1
|
$261,092
|
|
WAGNER, SHAWN
|
HYPERE, LLC
|
|
Preclinical Evaluation of VAX014 in Combination with Immune Checkpoint Inhibitors
|
1R43CA224450-01A1
|
$232,276
|
|
GIACALONE, MATTHEW
|
VAXIION THERAPEUTICS, INC.
|
|
Planning for a Sustainable and Robust RCRE in the Caribbean
|
5P20CA210294-02
|
$273,882
|
|
RAGIN, CAMILLE
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Physical Activity Platform to Improve Bone Health in Cancer Survivors
|
1R43CA224412-01A1
|
|
|
SKINNER, CATHERINE
|
THRIVORS, INC.
|
|
Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer
|
1R44CA224718-01A1
|
$159,365
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Personalized precision dosing of biologic therapies in oncology
|
5R44CA217336-02
|
$720,363
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
Total relevant funding to Stomach for this search: $11,367,881
|